Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disability accrual in primary and secondary progressive multiple sclerosis.

Journal of neurology, neurosurgery, and psychiatry·2023
Same author

Effect of Previous Disease-Modifying Therapy on Treatment Effectiveness for Patients Treated With Ocrelizumab.

Neurology(R) neuroimmunology & neuroinflammation·2023
Same author

Assessment of cognitive performance in multiple sclerosis using smartphone-based training games: a feasibility study.

Journal of neurology·2023
Same author

An investigation of the association between focal damage and global network properties in cognitively impaired and cognitively preserved patients with multiple sclerosis.

Frontiers in neuroscience·2023
Same author

Personalized maps of T1 relaxometry abnormalities provide correlates of disability in multiple sclerosis patients.

NeuroImage. Clinical·2023
Same author

Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple Sclerosis.

Neurology(R) neuroimmunology & neuroinflammation·2023

Related Experiment Video

Updated: Jun 11, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Measuring disability in relapsing-remitting MS

Richard A Rudick, Ludwig Kappos

    Neurology
    |July 2, 2010
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
    10:46

    A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

    Published on: December 9, 2015

    Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
    08:11

    Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

    Published on: November 14, 2016

    Related Experiment Videos

    Last Updated: Jun 11, 2026

    The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
    11:35

    The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

    Published on: June 30, 2014

    A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
    10:46

    A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

    Published on: December 9, 2015

    Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
    08:11

    Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

    Published on: November 14, 2016